Financhill
Back

VanEck Pharmaceutical ETF Vs. Ingevity Industry Stock Comparison

Sell
40

PPH
VanEck Pharmaceutical ETF

Last Price:
93.38
Seasonality Move:
3.76%
Sell
15

NGVT
Ingevity

Last Price:
37.03
Seasonality Move:
10.62%
Sell
40
VanEck Pharmaceutical ETF (PPH) is a Sell

Is VanEck Pharmaceutical ETF a Buy, Sell or Hold?

  • The current VanEck Pharmaceutical ETF [PPH] share price is $93.41. The Score for PPH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Ingevity (NGVT) is a Sell

Is Ingevity a Buy, Sell or Hold?

  • The current Ingevity [NGVT] share price is $37.04. The Score for NGVT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • NGVT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PPH Stock Price Chart

What is VanEck Pharmaceutical ETF's stock price today?

  • The VanEck Pharmaceutical ETF share price today is $93.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGVT Stock Price Chart

What is Ingevity's stock price today?

  • The Ingevity share price today is $37.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGVT is experiencing buying pressure, which is a positive indicator for future bullish movement.

PPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.75 Sell
Relative Strength Index (14 RSI): 29.41 Sell
Chaikin Money Flow: 389031 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (94.82 - 98.1) Sell
Bollinger Bands (100): (90.97 - 96.45) Sell

NGVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 47.28 Sell
Chaikin Money Flow: 509201 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 40.1) Sell
Bollinger Bands (100): (36.91 - 47.49) Sell

PPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 94.48 Sell
20-day SMA: 96.01 Sell
50-day SMA: 95.88 Sell
200-day SMA: 90.32 Buy
8-day EMA: 94.42 Sell
20-day EMA: 95.49 Sell
50-day EMA: 95.36 Sell
200-day EMA: 90.55 Buy

NGVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.05 Sell
20-day SMA: 37.78 Sell
50-day SMA: 38.09 Sell
200-day SMA: 44.29 Sell
8-day EMA: 37.4 Sell
20-day EMA: 37.93 Sell
50-day EMA: 38.95 Sell
200-day EMA: 43.92 Sell

VanEck Pharmaceutical ETF Earnings Growth & PPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ingevity Earnings Growth & NGVT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $1.18 per share.

VanEck Pharmaceutical ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ingevity Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):